Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of autologous myeloid dendritic cell therapeutic HIV-1 vaccine in early-stage HIV-1 infection
2004-003841-42Phase 2Active
- Sponsor
- Infectious Diseases Department, Hospital Clínic de Barcelona
- Start
- Oct 2005
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of autologous myeloid dendritic cells pulsed with inactivated autologous HIV-1 in human immunodeficiency virus infection (HIV), sponsored by Infectious Diseases Department, Hospital Clínic de Barcelona. Primary endpoint: Virologic set-point comparison. Started Oct 2005; status: active.
02
Drugs
autologous myeloid dendritic cells pulsed with inactivated autologous HIV-1
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-003841-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003841-42.